Veracyte Ownership | Who Owns Veracyte?
Veracyte Ownership Summary
Veracyte is owned by 109.23% institutional investors, 0.53% insiders. Vanguard group is the largest institutional shareholder, holding 10.66% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.92% of its assets in Veracyte shares.
VCYT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Veracyte | 109.23% | 0.53% | -9.76% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 306.69% | 11.10% | -217.79% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 8.21M | 10.66% | $325.18M |
| Blackrock | 7.79M | 10.42% | $168.88M |
| Blackrock funding, inc. /de | 7.73M | 9.88% | $208.90M |
| Artisan partners limited partnership | 6.32M | 8.08% | $170.88M |
| Wellington management group llp | 4.08M | 5.30% | $161.75M |
| Ark investment management | 3.80M | 4.86% | $102.72M |
| State street | 2.91M | 3.89% | $63.03M |
| Dimensional fund advisors lp | 2.88M | 3.74% | $114.16M |
| Arrowmark colorado | 2.58M | 3.30% | $69.71M |
| Fmr | 2.08M | 2.70% | $82.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Perkins capital management | 79.68K | 2.41% | $2.74M |
| Silverarc capital management | 448.50K | 2.24% | $12.12M |
| Palisades investment partners | 158.14K | 2.13% | $5.43M |
| Soleus capital management | 715.44K | 1.28% | $19.34M |
| Arrowmark colorado | 2.58M | 1.26% | $69.71M |
| Summit creek advisors | 248.13K | 1.24% | $8.52M |
| Efg asset management (north america) | 219.98K | 0.98% | $7.56M |
| Oberweis asset management inc/ | 726.49K | 0.85% | $19.64M |
| Granite investment partners | 636.22K | 0.84% | $17.20M |
| Ark investment management | 3.80M | 0.75% | $102.72M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.08M | 0.00% | 2.02M |
| Artisan partners limited partnership | 6.32M | 0.25% | 1.08M |
| Soleus capital management | 715.44K | 1.28% | 715.44K |
| Deerfield management company, l.p. (series c) | 625.00K | 0.31% | 625.00K |
| Blackrock | 7.79M | 0.00% | 581.69K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 2.91M | 0.00% | -1.42M |
| Driehaus capital management | - | - | -1.35M |
| William blair investment management | - | - | -811.79K |
| Assenagon asset management | 27.04K | 0.00% | -803.06K |
| Champlain investment partners | - | - | -800.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Soleus capital management | 715.44K | 1.28% | 715.44K | $19.34M |
| Deerfield management company, l.p. (series c) | 625.00K | 0.31% | 625.00K | $16.89M |
| Summit creek advisors | 248.13K | 1.24% | 248.13K | $8.52M |
| Norges bank | 225.60K | 0.00% | 225.60K | $8.93M |
| Abrdn | 181.92K | 0.01% | 181.92K | $4.92M |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -2.00 |
| Global financial private client | -5.00 |
| True wealth design | -6.00 |
| Kohmann bosshard financial services | -6.00 |
| Quadrant capital group | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 273 | -5.21% | 85,426,396 | 1.00% | 109 | 0.93% | 138 | 1.47% | 98 | -8.41% |
| Mar 31, 2025 | 9 | -97.20% | 3,530,599 | -95.70% | 4 | 0.04% | 5 | -96.84% | 3 | -97.41% |
| Dec 31, 2024 | 301 | 2.73% | 77,106,580 | -5.52% | 100 | 0.89% | 145 | -9.94% | 109 | 22.47% |
| Sep 30, 2024 | 292 | 22.18% | 81,612,672 | -0.60% | 105 | 0.88% | 162 | 38.46% | 88 | 7.32% |
| Jun 30, 2024 | 239 | -2.05% | 82,106,462 | 0.48% | 109 | 0.92% | 117 | -21.48% | 82 | 24.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.66M | 5.92% | - |
| ARK Innovation ETF | 2.96M | 3.77% | -45.42K |
| Vanguard US Total Market Shares ETF | 2.46M | 3.16% | 2.69K |
| Vanguard Total Stock Mkt Idx Inv | 2.44M | 3.11% | -51.87K |
| ARK Disruptive Innovation Full Composite | 2.36M | 3.00% | -119.19K |
| Vanguard Explorer Inv | 2.28M | 2.91% | -385.96K |
| Fidelity Select Medical Tech and Devcs | 2.00M | 2.54% | -230.00K |
| Vanguard Small Cap Index | 1.90M | 2.42% | -13.32K |
| iShares Russell 2000 ETF | 1.89M | 2.41% | - |
| Fidelity Select Health Care | 1.40M | 1.78% | -120.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 06, 2025 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | $300.71K |
| Oct 01, 2025 | Leite John | Chief Commercial Officer-CLIA | Sell | $88.86K |
| Oct 01, 2025 | EPSTEIN ROBERT S | - | Sell | $753.20K |
| Oct 01, 2025 | McGuire Annie | SVP, General Counsel | Sell | $75.61K |
| Sep 19, 2025 | McGuire Annie | SVP, General Counsel | Sell | $76.92K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 12 |
| 2024 Q4 | - | 13 |
VCYT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools